Clinical trial
A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy…
NCT00336310 · National Cheng-Kung University Hospital, Other · Unknown status
Key facts
| NCT number | NCT00336310 |
|---|---|
| Title | A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients |
| Official title | A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients |
| Lead sponsor | National Cheng-Kung University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Repaglinide |
| Enrollment | 50 |
| Start date | Jul 1, 2006 |
| First posted | Jun 13, 2006 |
| Last update posted | Jun 13, 2006 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: